Product Information
ARNUITY ELLIPTA 100 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $6.6475 per EA under NDC 00173087410. Its NADAC has been published 584 times since Jun 17, 2015.
FDA first approved this application on Aug 20, 2014.
Strength
100 ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173087410
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA205625FDA Approved
8/20/2014
On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for ARNUITY ELLIPTA 100 MCG INH has been published 584 times since Jun 17, 2015, and over the history we have for it it has risen 59.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6475 per EA |
|---|---|
| All-time high | $6.6771 (Oct 11, 2023) |
| All-time low | $4.1697 (Jul 22, 2015) |
| 52-week high | $6.6586 |
| 52-week low | $6.6475 |
| Median price | $5.8798 |
| Average price | $5.8341 |
| Largest weekly change | +8.5% (Dec 30, 2015) |
| Weeks tracked | 584 |
| Tracking since | Jun 17, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARNUITY ELLIPTA 100 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 100 MCG INH, manufactured by GlaxoSmithKline LLC, is $6.6475 per EA (NDC 00173087410), effective Aug 19, 2026.
How has the price of ARNUITY ELLIPTA 100 MCG INH changed over time?
Over the history we have for it, the NADAC for ARNUITY ELLIPTA 100 MCG INH has risen 59.2%. It has been tracked across 584 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 100 MCG INH?
Since Jun 17, 2015, the NADAC for ARNUITY ELLIPTA 100 MCG INH has ranged from a low of $4.1697 (Jul 22, 2015) to a high of $6.6771 (Oct 11, 2023), with a median of $5.8798 per EA.
Are there cheaper alternatives to ARNUITY ELLIPTA 100 MCG INH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 100 MCG INH, is $4.2969 per EA — about 35% below ARNUITY ELLIPTA 100 MCG INH.
Who manufactures ARNUITY ELLIPTA 100 MCG INH?
ARNUITY ELLIPTA 100 MCG INH (NDC 00173087410) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.